Alex Jones Responds To Mel Gibson Exposing Documented Cancer Cures Being Suppressed By Big Pharma

“All 3 of them had stage 4 Cancer”: There Is a “Cure” for Cancer, Mel Gibson and Joe Rogan Feel It’s Not Being Promoted Enough Mel Gibson and Joe Rogan discuss controversial cancer treatments while alleging how pharmaceuticals are suppressing these cures. Cancer has long been one of the most terrifying ailments in the history of humanity and an equally daunting challenge in modern medicine. And, despite billions of dollars being funded for research and treatment, medical experts have claimed to find rarely any solid cure for the disease. Amid such lack of progress, Mel Gibson joined Joe Rogan to ignite debate surrounding controversial cancer cures, during their recent podcast.  Appearing on The Joe Rogan Experience, Mel Gibson claimed how three of his friends, diagnosed with stage four cancer, found their cure in treatments that remain fraught with controversy. Sparking curiosity among listeners, Gibson and Rogan stated how they believe the potential cure for cancer is being suppressed by the medical establishments, for whatever reason.  Mel Gibson sparked curiosity with a controversial cure for cancer  After previously appearing on Joe Rogan’s podcast in 2018 and reflecting on his father’s stem cell cure, Mel Gibson once again paid a visit to The Joe Rogan Experience, in 2025. Yet again speaking on a series of intriguing claims about unconventional medical treatments, the actor and director Gibson set social media ablaze with his stories.  Speaking with the podcast host Joe Rogan on medical advancements and controversial treatments, Mel Gibson shared a story about three of his friends,…

Insurance company denies covering medication for condition that ‘could kill’ med student, she says

Malik JacksonUpdated: Dec 13, 2024 / 10:11 AM CST KANSAS CITY, Mo. (WDAF) — Blue Cross and Blue Shield of Kansas City denied coverage of a medicine that a Missouri woman says could save her life, leaving her with a monthly bill of over $8,000. “I was at risk for spontaneous internal bleeding that could kill me,” Kaitlyn Sy said. Sy, a University of Kansas medical student, said she’s fighting back just weeks after a near-death experience. She’s been forced to pause her medical studies while waiting for this medicine to be approved, compromising her already weak immune system. Sy conducted her interview with Nexstar’s WDAF over Zoom, unable to do it in person because of her condition. Sy has dreamed of becoming a doctor since middle school, “whether that be bringing hope and healing to fellow humans, intellectual stimulating work of diagnosing and treating diseases, being involved in medical research.”Luigi Mangione was reported missing 2 weeks before CEO slain: police  But three years ago, doctors diagnosed her with an autoimmune disease that mistakenly attacks the platelets in her blood cells. When she bleeds, there’s nothing to clot those cells. Sy says that could cause life-threatening bleeding. For years, no treatment worked well for her. Just weeks ago, that scenario happened: Sy was forced to go to the ER to treat internal bleeding. Her hematologist had one more option, a pill called Promacta that could stabilize this issue. Things changed when Sy got to the pharmacy. “The pharmacy tech — her…